0001973141-23-000210.txt : 20230908
0001973141-23-000210.hdr.sgml : 20230908
20230908160048
ACCESSION NUMBER: 0001973141-23-000210
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 231245248
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiBiase Mary
CENTRAL INDEX KEY: 0001880179
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET, 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
144
1
primary_doc.xml
144
0001880179
XXXXXXXX
LIVE
0001501697
X4 Pharmaceuticals, Inc
001-38295
61 NORTH BEACON STREET
4TH FLOOR
BOSTON
MA
02134
857-529-8300
DiBiase Mary
Officer
Common
UBS Financial Services, Inc.
1000 Harbor Blvd
3rd Floor
Weehawken
NJ
07086
2642
3276.00
164424897
09/08/2023
NASDAQ
Common
09/08/2023
Stock Award
Issuer
N
2642
09/08/2023
N/A
N
Mary DiBiase
61 NORTH BEACON STREET
4TH FLOOR
BOSTON
MA
02134
Common
06/15/2023
857
1911.28
Mary DiBiase
61 NORTH BEACON STREET
4TH FLOOR
BOSTON
MA
02134
Common
06/23/2023
857
1651.61
Mary DiBiase
61 NORTH BEACON STREET
4TH FLOOR
BOSTON
MA
02134
Common
06/30/2023
464
878.31
09/08/2023
09/29/2022
/s/ UBS Financial Services Inc, as attorney-in-fact for Mary DiBiase